Thermo Fisher Scientific Inc. (TMO) announced the opening of a Cryo-Electron Microscopy Drug Discovery Center in South San Francisco


Thermo Fisher Scientific Inc. (NYSE:TMO) is one The best stock that will always grow.

Thermo Fisher Scientific Inc. (TMO) announced the opening of a Cryo-Electron Microscopy Drug Discovery Center in South San Francisco
Thermo Fisher Scientific Inc. (TMO) announced the opening of a Cryo-Electron Microscopy Drug Discovery Center in South San Francisco

Thermo Fisher Scientific Inc. (NYSE:TMO) announced March 5 the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center in South San Francisco, offering biotechnology and pharmaceutical innovators access to advanced cryo-EM technologies and the development of unique structural specialty technologies. Life saving treatments.

Management further reported that the new center offers direct access to advanced cryo-EM innovation and scientific expertise, allowing for a significant reduction in barriers to adoption. It added that cryo-EM can be used to expand advanced therapies for therapeutic targets and structure-based methods, while enabling pharmaceutical companies to bring drugs to clinics faster. Thermo Fisher Scientific Inc. (NYSE:TMO), structure-directed medicine has double the clinical success rate in half the clinical time and half the cost compared to industry standards.

Glen Davis, Director of Materials and Structural Analysis, said the opening of the Cryo-EM Drug Discovery Center creates a collaborative environment that allows scientists to harness the power of cryo-EM to better understand disease at the molecular level and accelerate the development of treatments.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through analytical tools, life sciences solutions, laboratory products and services, and specialty diagnostics segments.

While we acknowledge the potential of TMO as an investment, we believe that some AI stocks offer more potential and lower risk. If you’re looking for the most undervalued AI stocks that stand to benefit significantly from Trump-era tariffs and the offshore trend, check out our free report Best short-term AI stocks.

Read more: The best and worst Dow stocks for the next 12 months and 10 unstoppable stocks that can double your money.

Disclosure: None. Follow the inside port on Google News.

Add Comment